Renhe Pharmacy (000650.SZ) subsidiary has obtained the registration certificate for Qingfei Tang granule medicine.
Renhe Pharmaceutical (000650.SZ) announced that recently, its wholly-owned subsidiary Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd. has received the "Drug Registration Certificate" for Qingfei Tang Granules issued by the National Medical Products Administration.
Renhe Pharmacy (000650.SZ) announced that its wholly-owned subsidiary, Jiangxi Yaodu Zhangshu Pharmaceutical Co., Ltd., has received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for Qingfei Tang granules.
Qingfei Tang granules are derived from the prescription of the famous physician Gong Tingxian of the Ming Dynasty's "Wanbing Huichun" and are the 67th prescription in the "Ancient Classic Famous Prescription Catalog (First Batch)". The prescription consists of 15 medicinal herbs including Scutellaria baicalensis, Platycodon grandiflorus, Poria, Citrus reticulata, Fritillaria thunbergii, Morus alba, Angelica sinensis, Ophiopogon japonicus, Gardenia jasminoides, Bitter apricot kernel, Ophiopogon japonicus, Schisandra chinensis, Licorice, Fresh ginger, and Chinese date. It has the functions of clearing heat, moistening the lungs, descending qi, and transforming phlegm, and is used to treat phlegm-heat cough with symptoms such as cough, wheezing, phlegm rattling in the throat, yellow and thick phlegm, or chronic hoarseness, red tongue with greasy yellow coating, and slippery rapid pulse.
Related Articles

CG Services (06098) on 22nd June spent 4.2774 million Hong Kong dollars to repurchase 81,700 shares.

ASSET CHAIN (00616) issued a profit alert, expecting the net comprehensive loss for the year to significantly narrow to not more than HK$80 million.

LIANLIAN (02598) spent HK$1.1645 million on June 22 to repurchase 255,000 shares.
CG Services (06098) on 22nd June spent 4.2774 million Hong Kong dollars to repurchase 81,700 shares.

ASSET CHAIN (00616) issued a profit alert, expecting the net comprehensive loss for the year to significantly narrow to not more than HK$80 million.

LIANLIAN (02598) spent HK$1.1645 million on June 22 to repurchase 255,000 shares.

RECOMMEND





